1 GIOVANNI FATTORE Curriculum Vitae

Transcript

1 GIOVANNI FATTORE Curriculum Vitae
GIOVANNI FATTORE
Curriculum Vitae
Personal data
Giovanni Fattore
Date and place of birth: November 16, 1963, Florence
Married, 1 child
Resident in Viale F. Crispi n° 5 Milano
Academic Positions in Italy
2007 September
2007 January – present
2006 April – 2006 September
2006 January – present
2005 September – present
2004 January – present
2002 April – 2008 June
2002 February – 2005 August
1997 June – 2002 January
1995 February – 1997 May
1989-1991 & 1994-1995
Executive Committee, Department of Institutional Analysis and
Public Management, Bocconi University.
Executive Committee, Centre Carlo F Dondena on Social
Dynamics, Bocconi University.
Acting Director, CERGAS (Centre for Research on Healthcare
Management and Social Care), Bocconi University.
Research Committee, Bocconi University
Associate Professor of Public and Healthcare Management, Bocconi
University.
Executive Committee, Vice-director for international projects,
CERGAS.
Director, Master of International Healthcare Management,
Economics and Policy (MIHMEP), Bocconi University.
Associate Professor of Management, Parthenope University,
Naples.
Assistant Professor of Public Management (Ricercatore), Bocconi
University.
Research Fellow, CERGAS, Bocconi University.
Research Officer (“Amici della Bocconi” scholarship), CERGAS.
International Academic Positions
January 2008
1998 February – 2001 March
2001 January
1999 September – October
2001 April
1996 January – 1997 June
1992 September – 1993 June
Instructor, New Public Management, Master in non-profit
management, Insbruck Management Centre, Insbruck
Instructor, “Health Policy” and “Quality Management”, Institute of
Public Health and University of Malta.
Instructor, “Comparative Healthcare Systems”, Msc in Health
Policy and Management, John Vianey Institute, Lahore, Pakistan.
Visiting Researcher, LSE-Health (London School of Economics),
sponsored by CNR (Italian Research Council), short-term mobility
program.
Instructor, “Principles of Pharmacoeconomics”, Faculty of
Medicine, Pontifical University of Chile, Santiago, Chile.
Research Officer, LSE-Health, London School of Economics.
Teaching Assistant, Harvard School of Public Health (course in
Decision Analysis, main instructor Prof. M.C. Weinstein).
1
Education
2008
1996 January – 1997 June
1993 June
1991 March
1989
PhD in Social Policy, London School of Economics and Political
Science (Tutor Julian Le Grand; thesis title “ A Cost.Benefit
Analysis of In-Vitro-Fertilization in Italy”)
Courses in “Research Methodology” and “Health Policy Research”,
London School of Economics.
MSc (2 years) in Health Policy and Management, Harvard
University (Decision Sciences track).
Course “Learning how to teach”, SDA Bocconi School of
Management.
Laurea degree in Economics (5 year programme) (DES, Discipline
Economiche e Sociali) summa cum laudae, Bocconi University.
Honors and Awards
2009
2008
2005
1996
1996
1992-1993
1989
Bocconi University, “Research Profile” for academic years 20092011
Bocconi University, “Excellence Research Award” -2008
CUD (Committee for Medical Devices) – Italian Ministry of
Health-, Expert Hearing about the use of economic evaluation for
medical devices.
Bocconi University, “Research Paper Award” -1996.
Italian Department of Health, “Official acknowledgement of
contribution to the analysis of the damage sustained by the Treasury
resulting from pharmaceutical policy in the period 1989-1992”.
Bocconi University, recipient of the President’s Scholarship for
Studies Abroad.
Bocconi University, top graduates’ award, academic year 19881989.
Government Research Grants (EU and Italy)
Sport & Social Capital (MEXT-CT-2005-025008) (Scientist in Charge since January 2008), Health
Basket (EU SP21-CT-2004-501588), Social Costs of Alzheimer Disease (EU – XT5-1998), Medicine for
Managers (EU 1996); PRIN 2007 (local unit leader), PRIN 2003 (local unit leader), COFIN 2001 (local unit
leader), COFIN 1999 (participant).
Refereeing
European Journal of Public Health, Journal of Health Politics Policy and Law, British Medical Journal,
Health Policy, Health Economics, Value in Health, European Management Review (special associate
editor), International Journal of Integrated Care, Journal of Management and Governance, Alzheimer
Disease and Associated Disorders, European Journal of Health Economics, International Journal of Health
Planning and Management, Epidemiologia e Psichiatria Sociale, Pharmacoeconomics Italian Research
Articles, Annali di Economia, Mecosan, Academy of Management Annual Conference.
Editorial Boards
Politiche Sanitarie, Pharmacoeconomics Italian Research Articles (associate editor),Italian Heart Journal
(1999-2002), Mecosan, Eurohealth.
2
Scientific Associations
•
•
•
•
•
•
•
Treasurer and Board member (2006 - 2009), European Association of Health Management (EHMA)
Board member (2002 to present), Vice President (2005-2008) and President (from 2008), Italian
Health Economics Association (AIES).
Member, Scientific Advisory Committee, European Health Management Association (2001-2004).
Member, International Advisory Board of Health Management, Management Education & Research
Consortium (M.E.R.C), Washington D.C (2006 to present).
Member, European Health Policy Research Network (led by the London School of Economics)
(1998-2202).
Member, Scientific Committee, Observatory on Health, Catholic University, Roma (2002 to
present).
Member, Board of the Heart Foundation (non-cardiologist member of the Foundation of the Italian
Association of Hospital Cardiologists) (2001-2004).
Main international conferences and seminars
-
-
-
DRGs: How, what why. The DRG as a financial tool. Bruxelles; European Parliament. Conference
organized by EHMA and HOPE, 5th March 2009.
PhD workshop, The Social Impact of Sport Management and Governance, Università Bocconi, 20
November, 2008.
Financing the social role of sport (session chair), The Social Impact of Sport Management and
Governance, 20-22 November, 2008.
7th European Health Economics Conference. The Italian National Health Service. Is Still National?
Rome, 24 July, 2008 (with F Longo).
IGR and the Welfare (Co-chair), The Status Inter-Governmental Relations, Fourth Transatlantic
Dialogue, Milan, 12-14 June, 2008.
2007 Conference of the American Evaluation Association. Process and use learning: a different
perspective. The case of the World Bank. Baltimore, 6-8 November 2008 (with S Paruzzolo).
HealthBasket Final Conference, Health baskets in Europe, 22 February, 2007.
Royal Holloway University (London University) PSRO seminar series, Health reforms in Italy ten years
later, University of London, December 8 2006.
WHO Europe, European Observatory on Health Care Systems and Government of Albania, Private
medicine and dual practice: the European experience (WORKSHOP), Tirana, 1-2 December 2006.
XXVII Conference of ALASS (Association for the Analysis of Latin Health Care Systems), “Health care
systems from globalization to local responses”, The impact of globalization on social justice, Milan, 6
October 2006. (with C De Pietro).
First EGPA (European Group for Public Administration) PhD and young research seminar, convener of
the event, Milan, 4-6 September 2006.
Second Annual HTAi Meeting (Bringing HTA into Practice), Decision making in Italian healthcare: are
economic studies used by decision makers, Rome, 20 June 2005.
International Society for Pharmacoeconomics and Outcome Research (ISPOR), The use of economic
evaluation in the Italian NHS, Hamburg, 23-25 October 2004.
Eucomed General Assembly (Forum on Economics of medical technologies), Medical Technology
Innovations: how can we afford it? Prague, 12 October 2004.
Creating Actionable Knowledge for Managing Change (International workshop to celebrate the XXV
anniversary of CERGAS), Economic evaluation in health care: are studies used by decision makers?,
Portofino, 9-10 September 2004.
Creating Actionable Knowledge for Managing Change (International workshop to celebrate the
XXVanniversary of CERGAS), Portofino, September 2004 (Scientific coordinator).
European Observatory on Health Care Systems, LSE and Government of Greece, Pharmaceutical Policy
in the European Union (workshop), The regulation of pharmaceutical market in Italy, Athens, 13 June
2003 (with C Jommi).
3
-
European Health Management Association Annual Conference, Should In Vitro Fertilisation be publicly
funded: a cost-benefit analysis for Italy, Orebro (Sweden), 23 June 2001.
European Health Policy Research Group (London School of Economics), Italian Health Policy, 7
February 2001.
European Health Management Association Annual Conference, Managing the demand side of health
care systems: comparing British and Italian primary care, Parma (Italy), June 2000.
European Health Policy Research Network, Rationing and Priority Setting in Italy, Athens, September
1998.
European Health Policy Forum, Market forces in European Health Care Systems: the industry
perspective, Louvain, 10 March 1998.
European Association of Self Medication, The Economic and social value of self-medication: an Italian
Study, Budapest, 6 September 1997.
Main scientific research projects and streams of research
2008-
The Italian healthcare reform: 30 years later. In preparation of various events celebrating
the 30th anniversary of the Italian NHS I have reviewed its developments with reference to
the concept of “governmentality”. Main scientific output: an article in Politiche Sanitarie
(forthcoming) and an abstract for EURAM 2009.
2007-
Social network analysis in primary care. I am leading two research projects on the use of
SNA to understand how knowledge is used and transferred among Italian GPs. We found
little evidence that institutional networks have an impact on physician’s prescribing
behavior. I have recently won a PRIN (Italian university research grant) on this topic.
2007
Voluntary Health Insurance (VHI) in Serbia. I prepared a policy paper for the World Bank
about the present situation and future developments of VHI in Serbia with a detailed review
of VHI in 8 European countries.
2006-2007
Universalism and excellence in the Regional Health Care System of Friuli Venezia Giulia. I
coordinated a project to review the institutional arrangements of the FVG regional
healthcare system and to recommend changes to the Governor of the Region. All top
managers of the regional health care system were interviewed and data of hospital activities
analyzed.
2003-2005
Impact of economic evaluation on decision making processes in the Italian NHS. I
investigated how economic evaluation principles and tools are used by decision makers at
policy, management and professional levels. Main research outputs: a paper presented at the
ISPOR conference in Hamburg (2004), two papers presented at the National Conference of
the Italian Health Economics Association and the manuscript “Economic evaluation in health
care: are studies used by decision makers?” (published in Value in Health).
2004-2007
Health Benefits and Service Costs in Europe –HealthBASKET. The project was funded by
the European Commission within the Sixth Framework Research Programme (Grant: SP21CT-2004-501588) and coordinated by Prof. Reinhard Busse, from the Dept. of Health Care
Management at the Technische Universität Berlin. I act as coordinator of the Bocconi team.
The study investigates basic healthcare packages in 8 EU member states through the
collection of original data on costs from a sample of European healthcare institutions. It aims
at defining and testing a new costing methodology to be used in Europe. Publications in The
European Journal of Health Economics and Health Care Management Science.
1997-
Pharmaceutical Observatory. The Observatory, established in 1997 as a unit of CERGASBocconi, carries out regular studies on Italian pharmaceutical policy, focusing on its impact
4
on the performance of healthcare organizations. It delivers two annual reports and occasional
discussion papers. I was head of the Observatory from 1997 to 2000 and I now act as
scientific supervisor. Main outputs: “The New Pharmaceutical Policy in Italy”, Health Policy
1998, “The last decade of Italian pharmaceutical policy: instability or consolidation”,
Pharmacoeconomics 2008, several articles in Italian scientific journals and informative
articles for Eurobserver, the Newsletter of the European Observatory on Health Care
Systems. The Pharmaceutical Observatory organised two international conferences at
Bocconi University (2000 and 2003) with prominent speakers from UK, Germany and the
US.
1994-2005
Economic evaluation of health care programmes and technologies. Since 1994, I have been
acting as scientific coordinator of the CERGAS unit on economic evaluations. The unit has
carried out several multi-centre empirical studies in cooperation with clinicians and
epidemiologists. Collection and analysis of primary data are performed to conduct cost-ofillness, cost-effectiveness, cost-utility and cost-benefit studies. The unit has investigated
drugs, new technologies and other healthcare programmes in the field of psychiatry,
cardiology, neurology, assisted reproductive medicine and public health. Main outputs: “The
costs of multiple sclerosis: a cross-sectional, multi-center cost-of-illness study in Italy”,
Journal of Neurology 2002; “Costs of pharmaceutical treatments in major depression
patients in Italy” Pharmacoeconomics 2000; “Mental Health Care in Italy: Organisational
Structure, Routine Clinical Activity and Costs of a Community Service in Lombardy
Region” International Journal of Social Psychiatry 2000; “Health care costs of therapyrefractory schizophrenic patients treated with clozapine: a study in a Community Psychiatric
Service in Italy”, Acta Psychiatrica Scandinavica 1999; The Economic and Social Burden of
Alzheimer Disease on Families in Lombardy Region, Italy”, Alzheimer Disease and
Associated Disorders 1997.
1993-2005
Comparative analysis of healthcare systems and policies. I have investigated health care
systems of the United States, Canada, United Kingdom, Germany, and several developing
countries. These research activities sustained my role as the Director of the Master of
International Healthcare Management, Economics and Policy. Main outputs: "Assetti
federali in Sanità: cosa possiamo imparare da Canada e Stati Uniti?", (in the 2003 SmithKline Foundation Report) and “Universalismo e sviluppo tecnologico: i sistemi sanitari della
Germania, del Regno Unito e degli Stati Uniti”, published in Rivista delle Politiche Sociali
2004. In 2003, I co-authored the report: “Health Care Financing: Options for the Syrian Arab
Republic”, sponsored by Italian Ministry of Foreign Affairs and presented to the SAR
Ministry of Health.
2002-
Managerialism in the Italian NHS. I am active in CERGAS Observatory on “Managerialism
in the Italian NHS” (OASI) and I prepared reports on regional health planning and, business
consultants’ perception of managerialism and health technology assessment. These reports
were published in the annual reports of the Observatory (2002 -2008).
2001
Vocational training in health management and economics in the European Union. I was
member of the international team coordinated by LSE-Health investigating vocational
training in the are of health economics and management. The study was based on a national
survey of health professionals’ needs for training in management and economics.
1998-1999
Priority setting in health care. The project, coordinated by Prof. Elias Mossialos of the
London School of Economics, investigated rationing and priority setting of health services in
10 EU member states. I wrote the Italian case and analysed data resulting from/generated by
the “Eurobarometer survey”. Main outputs: one paper presented at an international workshop
held in Athens in 1998 and the article “Clarifying the scope of Italian NHS coverage: Is it
feasible? Is it desirable?” in Health Policy 1999.
5
1995-1998
Health Care and Cost Containment in the European Union. The project, coordinated by
Prof. Elias Mossialos Julian Le Grand (LSE), investigated healthcare cost containment
policies in 12 UE member states. I was in charge of the Italian and the British study and,
during my stay in London from January 1996 to June 1997, I acted as coordinator of the
overall project. Main outputs: presentations in three workshops held in London and Brussels
and two chapters of the book “Health Care and Cost Containment in the European Union”
edited by E Mossialos and J Le Grand.
1997
Health in Transition Profile – United Kingdom -. I systematically reviewed the scientific
literature on the British NHS and drafted the Health in Transition Profile, a detailed
description of the British system, eventually published by the European Observatory on
Health Care Systems.
1992-1994
Cost-effectiveness analysis of prevention programmes for HIV. While at the Harvard School
of Public Health, I designed a simulation model to assess costs and outcomes of strategies to
prevent HIV and AIDS. Methods and results of the project were presented at a seminar for
the faculty and were published in the article "Economic Evaluation of HIV Testing Among
Intravenous Drug Users: Analytic Framework and Application to Italy", International
Journal of Technology Assessment in Health Care, 1996.
PhD supervision
•
•
•
•
•
•
•
•
Stefano Calciolari (Università di Parma, Public Management, XVI° ciclo, 2004), “Valutazione
economica dell’introduzione delle ICT nella pubblica amministrazione”.
Aleksandra Torbica (Università di Parma, Public Management, XIX° ciclo, 2007), “Tariff Setting in the
Italian National Health Service”.
Irene Colangelo (Università di Parma, Public Management, XX°, Ciclo 2008), “L’evoluzione del sistema
di finanziamento delle aziende sanitarie tramite DRG: Analisi delle scelte delle regioni italiane”.
Monica Otto (Università Bocconi, Business Administration and Management, XX° ciclo, 2008), “The
role of public administration in supporting biotech clusters”.
Antonio Lapenta (Università Magna Grecia di Catanzaro, Economia e Management in Sanità, 2008), “La
partecipazione é il suo contrario: Il Caso dell’Agenda di Riforma SP2010”
Domenico Salvatore (Università Bocconi, Business Administration and Management , XIX° Ciclo,
2008), “A Relational Approach to Health Care Management”.
Hans Dubois (Università Bocconi, Business Administration and Management, 2009) “Decentralization
in Public Administration”.
Silvia Paruzzolo (Università Bocconi, Business Administration and Management, 2009) “Participatory
evaluation as a tool to foster organizational learning: theory and evidence from the World Bank”.
Teaching Assignments (Bocconi University)
2009-2010
2008-2009
2007-2008
2006-2007
2005-2006
2004-2005
“Institutions, Government and Society”, “Public Management”
“Public Management”, “Management of Health Care and Social Services”
“Public Management”, “Management of Human Capital Services”, “Management of
Health Services and Social Care” (Bocconi and Vancouver Campus Abroad)
“Advanced Public Management” (for the PhD programme in Business
Administration and Management) “Management of Human Capital Services”,
“Management of Health Services and Social Care” and “Pharmaceutical and Biotech
Industry Laboratory ”.
“Advanced Public Management” (for the PhD programme in Business
Administration and Management), “Management of Human Capital Services”,
“Management of Health Services and Social Care”, “Pharmaceutical and Biotech
Industry Laboratory ”.
“Management of Human Capital Services”, “Pharmaceutical and Biotech Industry
Laboratory ”.
6
2003-2004
2002-2003
2001-2002
2000-2001
1999-2000
1999-2000
1998-1999
1997-1998
1996-1997
1995-1996
1994-1995
“Management of Human Capital Services”, “Pharmaceutical and Biotech Industry
Laboratory”, “Health Care Systems and Management”.
“Health Care Systems and Management”, “Comparative Public Management”.
“Health Care Systems and Management”, “Comparative Public Management”,
“Healthcare Management”.
“Health Care Systems and Management”, “Comparative Public Management”,
“Healthcare Management”, “Public Management”.
“Health Care Systems and Management”, “Comparative Public Management”,
“Healthcare Management”, “Public Management”.
Main instructor, “Health Care Systems and Management”, Instructor, “Comparative
Public Management”, “Healthcare Management”, “Public Management”.
Main instructor, “Health Care Systems and Management”, “Comparative Public
Management”, “Healthcare Management”.
“Comparative Public Management”, “Evaluation of Public Programmes”, “Public
Management”.
“Evaluation of Public Programmes”.
“Evaluation of Public Programmes”, “Public Management”.
“Evaluation of Public Programmes”.
Teaching and Management (SDA -Bocconi School of Management-)
- Core Faculty
- Director, Master of International Healthcare Management, Economics and Policy (MIHMEP) (2002-2008).
- Main instructor, “Healthcare Systems and Policy” (MIHMEP), “Comparative Healthcare Systems” (Master
in Management Sanitario), “Evaluation of Public Programmes” (Master in Public Management).
- Main Instructor, “Strategic Planning”, Executive Programme on Management for Health Professionals
(CorGeSan) (from 1994).
- Main instructor, “Quality management”, Executive program for Italian NHS general managers
- Instructor, Module on “Business in the pharmaceutical sector”, Master in Business Administration (20042006).
- Instructor, courses and seminars on health planning, strategic planning, quality management, knowledge
management, economic evaluation of healthcare programmes, management of pharmaceutical services,
health technology assessment, marketing in the pharmaceutical sector.
Teaching Assignments (Parthenope University, Naples)
2004-2005
2003-2004
2002-2003
2001-2002
“Introduction to Business Administration”, “Public Management”, “Healthcare
Management”.
“Introduction to Business Administration”, “Public Management”, “Healthcare
Management”.
“Public Management”, “Healthcare Management”.
“Enterprise Management”.
Other
-
Expert (reviewer) MAS Net-Megs in Economia e gestione sanitaria e sociosanitaria, Lugano,
Switzerland (September 2008-December 2008)
Member, Evaluation committee, Research Grants for Clinical Governance (4 Million Euros), Emilia
Romagna, Italy (October- 2008)
Member, Health Technology Assessment Expert Group, Lombardia Region, December 2008.
Author of dissemination articles published in Eurohealth and Eurobserver (international) and Sole 24,
Sole 24 Sanità, Prospettive Sociali e Sanitarie (Italian).
7
GIOVANNI FATTORE
List of Publications
Articles in Scientific Journals (English)
Dubois H, Fattore G, “Definitions and typologies in public administration research: The case of
decentralization”, International Journal of Public Administration 2009; 32(8): 704-727..
Cappellaro G, Fattore G, Torbica A, “Funding and Regulating Health Technologies in
Decentralized Systems: A Comparison between Italy and Spain”, Health Policy 2009; 92(3) 313321, (2009).
Fattore G, Frosini F, Salvatore D, Tozzi V, “Social Network Analysis in Primary Health Care: the impact of
interaction on prescribing behaviour”, Health Policy 2009; 92(3): 141-148.
Gerzeli S., Torbica A, Fattore G “Cost Utility Analysis of knee prosthesis with complete microprocessor
control (C-leg) compared with mechanical technology in trans-femoral amputees”, The European Journal of
Health Economics (HEPAC) 2008; 2: 327-336.
Fattore G, Jommi C “The last decade of Italian pharmaceutical policy: instability or consolidation?”,
Pharmacoeconomics 2008; 26(1):5-15.
Fattore G, Torbica A “Cost and reimbursement of cataract surgery in Europe: a cross-country comparison”,
Health Economics, 2008; 17 (S1): S71-S82.
Compagni A, Bartoli S, Buehrlen B, Fattore G, Ibarreta D, de Mesa EG “Avoiding adverse drug reactions by
pharmacogenetic testing: A systematic review of the economic evidence in the case of TPMT and AZAinduced side effects. International Journal of Technology Assessment in Health Care 2008; 24(3): 292-302.
Fattore G, Factors Affecting an Economic Model for Zoster Vaccination, Herpes 2007; 14 (S2): 52A-55A.
Fattore G, Torbica A “Inpatient reimbursement system in Italy: How do tariffs relate to costs?” Health Care
Management Science 2006; 9: 251-258.
Fattore G, Torbica A. “Economic evaluation in health care: the point of view of informed physicians”, Value
in Health 2006; 9(3): 157-167.
Torbica A, Fattore G. “The "Essential Levels of Care" in Italy: when being explicit serves the devolution of
powers”, The European Journal of Health Economics (HEPAC) 2005; 6: 46-52.
Amato, MP, Battaglia MA, Caputo D, Fattore G, Gerzeli S, Pitaro M, Reggio A “The costs of multiple
sclerosis: a cross-sectional, multicenter cost-of-illness study in Italy”, Journal of Neurology 2002; 249(2):
152-163.
Percudani M, Fattore G, Belloni GC, Gerzeli S, Contini A “Service utilization and costs of first-contact
patients in a community psychiatric service in Italy”, European Psychiatry 17 (8); 2002: 434-442.
Fattore G, Percudani M, Pugnoli C, Contini A, Beecham J “Mental Health Care in Italy: Organisational
Structure, Routine Clinical Activity and Costs of a Community Service in Lombardy Region”, International
Journal of Social Psychiatry 2000; 46(4): 250-265.
Tarricone R, Fattore G, Gerzeli S, Taddei C, Percudani M, “Costs of pharmaceutical treatments in major
depression patients in Italy” Pharmacoeconomics 2000; 15: 245-260.
8
Fattore G, “Clarifying the scope of Italian NHS coverage: Is it feasible? Is it desirable?” Health Policy 1999;
50: 123-142.
Percudani M, Fattore G, Galletta J, Mita P, Altamura C “Health care costs of therapy-refractory
schizophrenic patients treated with clozapine: a study in a Community Psychiatric Service in Italy”, Acta
Psychiatrica Scandinavica 1999; 99: 274-280.
Fattore G, Jommi C, “The New Pharmaceutical Policy in Italy”, Health Policy 1998; 46 (1); 21-41.
Lorenzoni R, Pagano D, Mazzotta G, Rosen D, Fattore G, Gensini G, “Pitfalls in the economic evaluation of
thrombolysis in myocardial infarction”, European Heart Journal 1998; 19(10): 1518-1524.
Cavallo M C, Fattore G “The Economic and Social Burden of Alzheimer Disease on Families in Lombardy
Region, Italy”, Alzheimer Disease and Associated Disorders 1997; 11(4): 184-190.
Villari P, Fattore G, Siegel J, Paltiel D, Weinstein M, "Economic Evaluation of HIV Testing Among
Intravenous Drug Users: Analytic Framework and Application to Italy", International Journal of Technology
Assessment in Health Care, 1996; 12(2): 329-350.
Book chapters (English)
Fattore G, “Cost-containment and reforms in the Italian National Health Service”. In: Mossialos E, Le Grand
J, editors. Health Care and Cost Containment in the European Union. Aldershot: Ashgate 1999; 513-546.
Fattore G, “Cost-containment in the British National Health Service”. In: Mossialos E, Le Grand J, editors.
Health Care and Cost Containment in the European Union. Aldershot: Ashgate. 1999: 733-781.
Articles in Scientific Journals (Italian)
Fattore G, Crisio economica, salute e sistema sanitario, Politiche Sanitarie 2009; 19(2): 49-53.
Fattore G, Politica, aziende, professionisti e pazienti: 30 anni di governo del Ssn (Politics,
organizations,professionals and patients: governing the Italian NHS in the last 30 years), Politiche Sanitarie
2008; 9(4): 173-182.
Fattore G, “I National Health Service del Regno Unito: verso il modello italiano?” (The British NHS:
towards the Italian model?), Mecosan 2008; 65: 83-95.
Fattore G, Jommi C. “La politica farmaceutica in Italia nell’ultimo decennio” (Pharmaceutical policy in the
last decade), Pharmaceonomics Italian Research Articles 2008; 9(3) 2-13.
Fattore G, Torbica A, “Il ruolo delle variabili organizzative nella diffusione dell’innovazione tecnologica: il
caso dell’infarto miocardico acuto” (The role of organizational variables in the diffusion of technological
innovations: the case of Acute Miocardial Infarction), Economia e Politica del Farmaco 2007; 7: 27-38.
Aguzzi G, Fattore G, “L’analisi dei costi di produzione dei servizi e l’utilizzo delle tariffe nelle valutazioni
economiche in sanità” (Cost analysis and tariffs in economic evaluation studies), Pharmaceonomics Italian
Research Articles 2006; 8(1): 62-66.
Fattore G, Landolina M, Bontempi L, Cacciatore G, Curnis A, Gilizia M, Padeletti L, Mazzei L, Tavazzi L,
“L’impatto economico della terapia di resincronizzazione in pazienti con scompenso cardiaco. Evidenze
9
disponibili e valutazione del modello CRT-Eucomed per l’analisi dei rapporto costo-efficacia”, (The
economic impact of resyncronisation: an economic simulation) Italian Heart Journal 2005: 6(12): 796-803.
Fattore G, Torbica A, Mangone M, “Analisi dei costi di quattro strategie terapeutiche nella gestione di
pazienti con broncopneumopatia (BPCO) moderata o severa: un’applicazione del metodo bootstrap” (Cost
analysis of 4 strategies for the management of patients with moderate or severe bronchoneopathy: a bootstrap
analysis), Pharmacoeconomics Italian Research Articles 2005; 7(2): 135-143.
Fattore G, “Costi ed efficacia devono essere scontati allo stesso tasso?” (Should cost and effectiveness be
discounted at the same rate?) Pharmacoeconomics Italian Research Articles 2005; 7(1): 5-7.
Fattore G, “Universalismo e sviluppo tecnologico: i sistemi sanitari della Germania, del Regno Unito e degli
Stati Uniti (Universalism and technological development: the health care systems of Germany, UK and
United States)”, Rivista delle Politiche Sociali 2004; 4: 55-72.
Fattore G, Colangelo I, Martelli E, Cheli A, Del Sasso L, “Metodi e costi della profilassi della trombosi
venosa profonda in chirurgia ortopedica in Italia”, (Methods of prevention and costs of deep trombosis in
orthopaedic surgery patients) Pharmacoeconomics Italian Research Articles 2004; 6(2): 69-80.
Percudani M, Gerzeli S, Massagrandi R, Jommi C, Fattore G, Cerati G, Contini A "Costi ed esito
dell'assistenza nei soggetti con disturbo mentale grave" (Cost and outcome for care of severe psychiatric
disorders), Epidemiologia e Psichiatria Sociale 2003; 12(3): 175-186.
Fattore G, Lazzaro C “Analisi dei costi della somministrazione di albumina nel paziente cirrotico con ascite”
(Cost analysis of albumina in cirrosis patients), Mecosan 2001; 40: 53-65.
Bensa G, Fattore G “Il Piano Sanitario dell’Oregon: la strategia politica del razionamento” (The Oregon
Plan: the political strategy of rationing), Mecosan 2000; 36: 139-145.
Fattore G, Lazzaro C “Analisi dei costi del trattamento della menoraggia” (Cost analysis of menhoraggia
treatments), Pharmacoeconomics Italian Research Articles 1999; 1(1): 1-15.
Attanasio E, Bruzzi P, Capri S, Ceci A, Fattore G, Mantovani L, “Raccomandazioni per la conduzione degli
studi di farmacoeconomia: la gida GISF” (Reccomendations to conduct pharmacoeconomic studies)
Mecosan 1999; 29: 65-72.
Fattore G, Lazzaro C “Analisi costi-efficacia della fertilizzazione in vitro in Italia” (Cost-effectiveness
analysis of In-Vitro-Fertilization in Italy), Mecosan 1998; 25: 37-52.
Lorenzoni R, Fattore G, Gensini G “Valutazione costi-efficacia della terapia trombolitica nell’infarto
miocardico acuto con Attivatore Tissutale del Plasminogeno o con Streptochinasi: la realtà italiana” (Costeffectiveness analysis of thrombolytic therapies in AMI patients: the Italian situation), Giornale Italiano di
Cardiologia 1997; 27(7): 721-726.
Fattore G, Percudani M, Tarricone R, Recchia M, Serra G, Taddei C “L’assistenza ospedaliera nella
depressione maggiore: risultati di uno studio osservazionale multicentrico” (Hospital care in major
depression patients: results from a multi-centre study), Rivista di Psichiatria 1997; 32(5): 189-197.
Fattore G, Percudani M, Pugnoli C, Contini A, “I costi delle prestazioni in psichiatria: un’analisi condotta in
un Centro Psico-Sociale pubblico (CPS) in Lombardia” (Costs of psychiatric care in a Mental Health Centre
in Lombardy Region), Epidemiologia e Psichiatria Sociale 1997; 6(2): 139-147.
Fattore G, Jommi C, “Il prezzo dei farmaci innovativi tra regolazione pubblica e mercato” (The price of
innovative drugs), Mecosan 1997; 22: 103-111.
10
Fattore G, Tabacchi M, “Economia e Management: cosa ne pensano i medici: una indagine nazionale”
(Economics and management: what do doctors think about that?), Annali di Igiene, prevenzione e di
Medicina di Comunità 1997; 9: 329-340.
Fattore G, Longo F, “Il fundholding nel Regno Unito: appunti da un viaggio di studio” (Fundholding in the
British NHS: notes from a field trip), Mecosan 1996; 18: 110-122.
Fattore G, “Sistemi di competizione amministrata nel SSN: modelli di finanziamento a tariffa e modelli
negoziali” (Systems of managed competition in the NHS:the tariff-based versus the purchaser-provider split
model). Mecosan 1996; 19: 50-55.
Fattore G, "Analisi costi-efficacia del trattamento e della prevenzione con aspirina in pazienti con sospetto
infarto miocardico acuto ed alto rischio di incidenti vascolari" (Cost-effectiveness analysis of suspected
Acute Miocardial Infarction), Mecosan, 1995, 14: 13-25.
Percudani M, Fattore G, Strada L, Contini A, "La valutazione dei costi diretti e indiretti della depressione
maggiore: applicazione di una metodologia di indagine in un servizio psichiatrico pubblico" (Cost analysis of
major depression), Epidemiologia e Psichiatria Sociale: 1995, 4(3): 198-211.
Fattore G, “Valutazione farmacoeconomica delle strategie di prevenzione degli eventi cardiovascolari”
(Pharmaco-economic analysis of cardiovascular prevention), Cardiologia 1995; 40 (12 Sup 1): 435-440.
Cavallo M C, Fattore G, "I costi sociali della Malattia di Alzheimer: metodologia e risultati di una indagine
preliminare"(Social costs of Alzheimer Disease), Mecosan 1994, 10: 12-23.
Fattore G, "Le risorse diminuiscono, i sistemi sanitari cambiano: due esempi, il sistema sanitario inglese e
quello americano" (Diminuishing resources and increasing needs: how the Italian and British health care
systems are changing), Giornale Italiano di Cardiologia 1994, 9: 1461-1466.
Fattore G, Meneguzzo M, Tarricone R (a cura di) "Who shall live, Who shall die?", Mecosan 1993, 5: 106120.
Fattore G, "Il mercato assicurativo privato in sanità: cenni alla teoria economica" (Private health insurance in
health care), Mecosan, 1993, 7: 10-17.
Fattore G, "Il sistema sanitario americano: tra crisi e innovazione" (The US health care system: between
crisis and innovation), Mecosan 1992, 3: 84-95.
Fattore G, Garattini L, "L'allocazione delle risorse finanziarie nel Servizio Sanitario Nazionale: il quadro
teorico e una soluzione pratica" (The allocation of financial resources in the Italian NHS), Economia
Pubblica 1989, 12: 541-556.
Books and book chapters (Italian)
Fattore G, Cavallo MC, Tarricone R, “Lo sviluppo del Health Technology Assessment in Italia: contenuti,
approcci e riferimenti internazionali” (Health Technology Assessment in Italy). In Anessi Pessina E, Cantù E
(a cura di), L’aziendalizzazione in sanità in Italia. Rapporto OASI 2008, Milano, Egea, 2008.
Fattore G, “Rilevanza e complessità delle amministrazioni pubbliche” (Relevance and complexity of public
institutions). In Borgonovi E., Fattore G., Longo., F. (a cura di), Management delle Istituzioni Pubbliche,
Milano, Egea, 2008 (3-16).
11
Borgonovi E, Fattore G, “I concetti fondamentali per lo studio delle amministrazioni pubbliche”
(Fundamentals in the study of public management). In Borgonovi E, Fattore G, Longo F, Management delle
Istituzioni Pubbliche, Milano, Egea, 2008 (17-32).
Fattore G, “Le funzioni delle istituzioni pubbliche” (Main functions of public institutions). In Borgonovi E.,
Fattore G., Longo., F. Management delle Istituzioni Pubbliche, Milano, Egea, 2008 (33-46).
Borgonovi E, Fattore G “Caratteristiche e specificità del management pubblico” (Peculiarity of public
management) . In Borgonovi E, Fattore G, Longo F. Management delle Istituzioni Pubbliche, Milano, Egea
2008 (47-62).
Bartoli S, Fattore G “Italia ed Europa, un confronto in sanità: il progetto EU Health Basket”, (Italy and
Europe: results from the Health Basket project). In Anessi Pessina E, Cantù E., L'aziendalizzazione in
sanità in Italia. Rapporto OASI 2007, Milano, Egea, 2007.
Aguzzi G, Fattore G, Lecci F “I Piani Sanitari Nazionali: quale ruolo per lo Stato nella
programmazione di un sistema decentrato” (Health Planning: which role in the Italian NHS?), In
Anessi Pessina E, Cantù E., L'aziendalizzazione in sanità in Italia. Rapporto OASI 2006, Milano, Egea,
2006.
“Prefazione”. Spar D. Baby Business, Milano, Egea 2006.
Fattore G, “Scenari della sanità: il futuro dei servizi” (Future scenarios for the Italian healthcare system: the
organizational dimension), In Cislaghi C. Gli Scenari in Sanità, Milano, Franco Angeli, 2006.
Fattore G, Lecci F “I piani sanitari delle Regioni italiane” (Regional health planning), In Anessi Pessina E,
Cantù E., L'aziendalizzazione in sanità in Italia. Rapporto OASI 2005, Milan, Egea, 2005.
Fattore G, Metodi di ricerca in economia aziendale (Research methods in management), Milan, Egea, 2005.
Fattore G, “L’aziendalizzazione della sanità in Italia: la prospettiva dei consulenti” (Managerialism in
healthcare: what do consultants think?). In Anessi Pessina E, Cantù E., L'aziendalizzazione in sanità in
Italia. Rapporto OASI 2004, Milano, Egea, 2004.
Fattore G, Tozzi V, “Innovazione di processo, knowledge practice e performance assistenziali: il caso
dell’Ospedale degli Infermi di Biella” (Innovation, knowledge and perfromance: the case of the Biella
Hospital). In AA. VV. Knowledge Management e Successo Aziendale. Atti del 26° Congresso Aidea. Agf
AIDEA, Udine, 2004.
Fattore G, "Assetti federali in Sanità: cosa possiamo imparare da Canada e Stati Uniti?" (Healthcare
federalism: lessons from Canada and the US) In Falcitelli N, Trabucchi M, Vanara F (ed), Rapporto Sanità
2003. Il governo dei sistemi sanitari tra programmazione, devolution e valorizzazione delle autonomie,
Bologna, Il Mulino, 2003.
Fattore G, Longo F "Le tendenze evolutive nei sistemi regionali: analisi di alcuni piani sanitari
rappresentativi" (Trends in regional health planning). In Anessi Pessina E., Cantù E., L'aziendalizzazione in
sanità in Italia. Rapporto OASI 2002, Milan, Egea, 2002.
Fattore G, Politiche centrali e regionali di governo della spesa farmaceutica a carico del SSN Central and
regional pharmaceutical policies), in AAVV. Autonomia regionale e sistema sanitario. Atti del IV workshop
di Economia Sanitaria, Torino, 1999.
Cavallo MC, Fattore G, Tarricone R, Farmacoeconomia: Introduzione all’analisi costi-efficacia, costi-utilità
e delle decisioni (Pharmacoeconomics: introduction to cost-effectiveness, cost-utility and decision analysis),
Milan, Promofarma, 1998.
12
Fattore G, “La regolamentazione dei prezzi”(Price regulation). In Lucioni C, Minghetti P. (a cura di).
Economia e normativa del farmaco, Torino, Utet, 1998.
Fattore G, “Finanziamento e governo dell’assistenza farmaceutica” (Funding pharmaceutical care), In
Lucioni C, Minghetti P. (a cura di). Economia e normativa del farmaco, Torino, Utet, 1998.
Fattore G, Percudani M “La valutazione economica dei trattamenti psicofarmacologici” (Economic analysis
of pharmaceutical treatments in psychiatry) in Altamura A. C. (a cura di), Argomenti di clinica e
farmacoterapia delle psicosi maggiori, Milano, McGraw-Hill, 1996.
Fattore G, Castaldi S "I Trust ospedalieri e il sistema sanitario pubblico di Londra" (Hospital Trusts in the
public health care system in London), in Meneguzzo M. (a cura di) Strategie e gestione delle reti di aziende
sanitarie , Milano, Egea, 1996.
Fattore G, "La riforma del sistema sanitario svedese e il modello di offerta dei servizi della città di
Stoccolma” (Reforming healthcare in Stockholm) in Meneguzzo M. (a cura di) Strategie e gestione delle reti
dei aziende sanitarie, Milano, Egea, 1996.
Fattore G, "L'analisi di alcune unità sanitarie Locali" (A study on management innovation in Italian Local
Health Units), in Borgonovi E. et al., Stato ed Economia. Lo Stato come Spende, Centro Studi Confindustria,
Milano, Il Sole 24 Ore 1988.
13